FSU Dermatology Grand Rounds
Systemic Therapies: Rituximab, Thalidomide & Anti-TNF Drugs for Management of Complex Dermatoses
At the conclusion, the participant should be able to:
1) IDENTIFY therapeutic options for managing cutaneous lupus, prurigo nodularis, and pyoderma gangrenosum; 2) DISCUSS the pros and cons of systemic therapy with rituximab, anti-tnf drugs and thalidomide; 3) RECOGNIZE the risks and benefits of using systemic medications off label to manage complex dermatoses.
Questions and answers will allow for audience participation.